• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Hearing Loss, Brain Structure, Cognition, and Dementia Risk in the Framingham Heart Study

byJayden BerdugoandSimon Pan
November 12, 2025
in Chronic Disease, Genetics, Neurology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this cohort study, midlife hearing loss was linked with smaller brain volumes, faster decline in executive function, and a higher risk of developing dementia, particularly in those carrying the apolipoprotein E ε4 allele. 

Evidence Rating Level: 1 (Excellent) 

Age-related hearing loss has been linked by studies as a major risk factor for dementia, with several others noting the association between age-related hearing loss and poorer cognition. This study, using data from the Framingham Heart Study (FHS) Offspring Study, a 3-generational cohort study, examined the link between hearing loss with a multitude of brain outcomes, including those measured by MRI and neuropsychological ones. The presence of the apolipoprotein E (APOE) ε4 allele was used to evaluate the association and the value of hearing loss as a predictive risk factor for dementia. 1656 participants were studied and examined by certified audiologists for Pure Tone Averages (PTA), with patient histories obtained. A large spectrum of cognitive tests was run to link brain outcomes. The study found links between hearing loss and decline in brain function, with increasing PTA thresholds linearly associated with a greater increase in white matter hyperintensity volume (β [SE], 0.02 [0.01]; P = .048) and a greater decline in TMT-B minus TMT-A performance (β [SE], −0.02 [0.01]; P = .02). 12.7% of patients from a sample developed dementia, with a higher risk shown for those with any hearing loss (HR, 1.71; 95% CI, 1.01-2.90; P = .045). Those who did not use hearing aids showed a slightly elevated risk compared to those who did (HR, 1.72; 95% CI, 1.02-2.91; P = .04), with the primary risk being seen in APOE ε4 carriers (HR, 2.82; 95% CI, 1.11-7.16; P = .03). Overall, any more than a slight hearing loss showed 70% increase in dementia risk. The links between the two may be due to isolation or decreases in brain connectivity. Hearing loss can thus be seen to not just affect quality of life, but also brain health.

Click here to read this study in JAMA Network Open

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Diphenhydramine, Sodium Bicarbonate, or Combination for Acute Peripheral Vertigo: A Randomized Clinical Trial

Risk of Parkinson’s disease after human papillomavirus infection: a nationwide cohort study

Diphenhydramine, Sodium Bicarbonate, or Combination for Acute Peripheral Vertigo

Tags: dementiaexecutive functionhearing lossneurologyneuropsychiatry
Previous Post

Hysterectomy Status and Outcomes in Patients With Grade 1, Stage IA Endometrioid Adenocarcinoma 

Next Post

Risk of Parkinson’s disease after human papillomavirus infection: a nationwide cohort study

RelatedReports

Brain lesions on MRI linked with subsequent increased stroke risk
Chronic Disease

Diphenhydramine, Sodium Bicarbonate, or Combination for Acute Peripheral Vertigo: A Randomized Clinical Trial

November 14, 2025
2 Minute Medicine Rewind August 19, 2019
Chronic Disease

Risk of Parkinson’s disease after human papillomavirus infection: a nationwide cohort study

November 13, 2025
Abusive head trauma results in fewer productive life-years
Emergency

Diphenhydramine, Sodium Bicarbonate, or Combination for Acute Peripheral Vertigo

November 10, 2025
Weekly Rewinds

2 Minute Medicine Rewind November 10th, 2025

November 10, 2025
Next Post
2 Minute Medicine Rewind August 19, 2019

Risk of Parkinson’s disease after human papillomavirus infection: a nationwide cohort study

Brain lesions on MRI linked with subsequent increased stroke risk

Diphenhydramine, Sodium Bicarbonate, or Combination for Acute Peripheral Vertigo: A Randomized Clinical Trial

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Diphenhydramine, Sodium Bicarbonate, or Combination for Acute Peripheral Vertigo: A Randomized Clinical Trial
  • Risk of Parkinson’s disease after human papillomavirus infection: a nationwide cohort study
  • Hearing Loss, Brain Structure, Cognition, and Dementia Risk in the Framingham Heart Study
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.